BRIEF published on 04/26/2024 at 07:20, 1 year 10 months ago Résultats annuels 2023 de Grolleau : Une dynamique de croissance malgré les défis Chiffre D'affaires Résultats Financiers 2023 Projections 2024 Grolleau Marge EBE
BRIEF published on 04/26/2024 at 07:20, 1 year 10 months ago Grolleau 2023 annual results: Growth dynamics despite challenges EBITDA Margin 2023 Financial Results Turnover 2024 Projections Grolleau
BRIEF published on 04/26/2024 at 07:06, 1 year 10 months ago PALFINGER AG Reports Strong Performance in Q1 2024 Despite Market Challenges Sustainability Market Challenges PALFINGER AG Q1 2024 Financial Results Marine Sector Growth
BRIEF published on 04/26/2024 at 07:06, 1 year 10 months ago PALFINGER AG annonce de solides performances au premier trimestre 2024 malgré les défis du marché Durabilité Défis Du Marché PALFINGER SA Résultats Financiers Du Premier Trimestre 2024 Croissance Du Secteur Maritime
BRIEF published on 04/26/2024 at 07:05, 1 year 10 months ago Assemblée générale ordinaire d’Espace Real Estate Holding AG Stratégie D'entreprise Assemblée Générale Dividendes Espace Real Estate AG Réélection
BRIEF published on 04/26/2024 at 07:05, 1 year 10 months ago Ordinary general meeting of Espace Real Estate Holding AG Business Strategy Dividends Re-election General Assembly Espace Real Estate AG
BRIEF published on 04/26/2024 at 07:05, 1 year 10 months ago Completion of Business Combination between Kinarus Therapeutics and Curatis AG Pharmaceuticals Business Combination Stock Market Curatis Holding AG Orphan Diseases
BRIEF published on 04/26/2024 at 07:05, 1 year 10 months ago Finalisation du regroupement d'entreprises entre Kinarus Therapeutics et Curatis AG Bourse Combinaison Commerciale Médicaments Curatis Holding SA Maladies Orphelines
BRIEF published on 04/26/2024 at 07:05, 1 year 10 months ago BB Biotech AG Announces Strong First Quarter Results in 2024 Interim Report Financial Performance Net Profit BB Biotech AG Interim Report 2024 Biotechnology Investments
BRIEF published on 04/26/2024 at 07:05, 1 year 10 months ago BB Biotech AG annonce de solides résultats du premier trimestre dans son rapport intermédiaire 2024 Performance Financière Bénéfice Net BB Biotech SA Rapport Intermédiaire 2024 Investissements En Biotechnologie
Published on 03/19/2026 at 06:35, 52 minutes ago Golden Lake Announces Securityholder Approval of Arrangement with McEwen Inc.
Published on 03/19/2026 at 01:05, 6 hours 22 minutes ago Prospect Ridge Announces Closing of Flow-Through Share Private Placement
Published on 03/18/2026 at 23:45, 7 hours 42 minutes ago Orogen Royalties Announces Private Placement Update
Published on 03/18/2026 at 21:00, 10 hours 27 minutes ago PLDT's Smart Selects Amdocs to Transform Retail Operations with AI-Powered Store Genie
Published on 03/18/2026 at 19:05, 12 hours 22 minutes ago Deposit Modeling at Thor Shows that the Proven Thor Epithermal Deposit is Flanked on Both Sides by a Much Larger Deposit
Published on 03/19/2026 at 07:03, 23 minutes ago Ad hoc Matador Secondary Private Equity AG - annual report 2025_CHF 4.3m in profit and CHF 6.6m in cash distributions from the private equity portfolio, currency-adjusted profit 1.9m CHF
Published on 03/19/2026 at 07:01, 25 minutes ago Cembra publishes invitation to the Annual General Meeting 2026 and its Annual Report 2025
Published on 03/19/2026 at 07:00, 26 minutes ago Financial year 2025: SBO advances strategic recalibration - solid 2025 results in a challenging market environment
Published on 03/19/2026 at 07:00, 26 minutes ago Following a successful fiscal year 2025, Nemetschek Group targets continued strong revenue growth with higher profitability
Published on 03/19/2026 at 07:00, 27 minutes ago bioMérieux Receives IVDR CE‑Marking for Two BIOFIRE® SPOTFIRE® Panels to Strengthen Near‑Patient Respiratory and Sore Throat Diagnostics Across Europe
Published on 03/19/2026 at 07:00, 27 minutes ago bioMérieux obtient le marquage CE IVDR pour deux tests BIOFIRE® SPOTFIRE® afin de renforcer en Europe le diagnostic des infections respiratoires et pharyngées au plus près du patient
Published on 03/19/2026 at 07:00, 27 minutes ago Résultats annuels 2025 et nouvelle signature stratégique
Published on 03/18/2026 at 19:41, 11 hours 46 minutes ago Covivio - Conditions of availability of the 2025 Universal Registration Document
